Found: 18
Select item for more details and to access through your institution.
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1620, doi. 10.1002/ajh.27367
- By:
- Publication type:
- Article
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1192, doi. 10.1002/ajh.27304
- By:
- Publication type:
- Article
Management of front line chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26677
- By:
- Publication type:
- Article
Management of front line chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26677
- By:
- Publication type:
- Article
Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E457, doi. 10.1002/ajh.26363
- By:
- Publication type:
- Article
Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1112, doi. 10.1002/ajh.26260
- By:
- Publication type:
- Article
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1002, doi. 10.1002/ajh.25561
- By:
- Publication type:
- Article
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. E239, doi. 10.1002/ajh.23841
- By:
- Publication type:
- Article
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
- By:
- Publication type:
- Article
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
- By:
- Publication type:
- Article
Hybrid immunity to SARS‐CoV‐2 in patients with chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 5, p. 788, doi. 10.1111/ejh.14170
- By:
- Publication type:
- Article
Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 10, p. 1, doi. 10.1038/s41408-021-00556-7
- By:
- Publication type:
- Article
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 253, doi. 10.1111/ejh.12714
- By:
- Publication type:
- Article
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 727, doi. 10.1111/bjh.15604
- By:
- Publication type:
- Article
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 12, p. 2258, doi. 10.1002/cncr.27972
- By:
- Publication type:
- Article
Monoklonale Antikörper bei Lymphomen.
- Published in:
- Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur Medizin und Naturwissenschaften), 2005, v. 55, n. 11, p. 704
- By:
- Publication type:
- Article
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3083, doi. 10.1007/s00277-023-05314-2
- By:
- Publication type:
- Article